J&J seeks US authorisation for its COVID booster shot
Al Jazeera
A panel of FDA health experts will meet next week to consider booster shots of the J&J and Moderna vaccines.
Drugmaker Johnson & Johnson has asked United States regulators for emergency use authorisation of its COVID-19 booster shot, the company announced, as the US government moves to expand its booster campaign to millions of vaccinated Americans.
J&J said on Tuesday that it requested the US Food and Drug Administration (FDA) authorise boosters for people aged 18 and older who previously received the company’s one-shot vaccine.
The drugmaker also said its submission includes data from a late-stage study that found a booster given 56 days after the primary dose provided 94 percent protection against symptomatic COVID-19 in the US and 100 percent protection against severe disease, at least 14 days after the booster shot.
